Reactive Oxygen Species Induced p53 Activation: DNA Damage, Redox Signaling, or Both?
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Significance: The p53 tumor suppressor has been dubbed the “guardian of genome” because of its various roles in the response to DNA damage such as DNA damage repair, cell cycle arrest, senescence, and apoptosis, all of which are in place to prevent mutations from being passed on down the lineage. Recent Advances: Reactive oxygen species (ROS), for instance hydrogen peroxide derived from mitochondrial respiration, have long been regarded mainly as a major source of cellular damage to DNA and other macromolecules. Critical Issues: More recently, ROS have been shown to also play important physiological roles as second messengers in so-called redox signaling. It is, therefore, not clear whether the observed activation of p53 by ROS is mediated through the DNA damage response, redox signaling, or both. In this review, we will discuss the similarities and differences between p53 activation in response to DNA damage and redox signaling in terms of upstream signaling and downstream transcriptional program activation. Future Directions: Understanding whether and how DNA damage and redox signaling-dependent p53 activation can be dissected could be useful to develop anti-cancer therapeutic p53-reactivation strategies that do not depend on the induction of DNA damage and the resulting additional mutational load.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aging: a theory based on free radical and radiation chemistry
Harman, D. (1956) · Journal of Gerontology · doi:10.1093/geronj/11.3.298 · Cited by 8,567
How mitochondria produce reactive oxygen species
Murphy, M. P. (2009) · Biochemical Journal · doi:10.1042/bj20081386 · Cited by 8,207
Regulation of Ferroptotic Cancer Cell Death by GPX4
Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., et al. (2014) · Cell · doi:10.1016/j.cell.2013.12.010 · Cited by 7,713
The Warburg Effect: How Does it Benefit Cancer Cells?
Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · cited 8×
“Furthermore, p53 transcriptional targets play several roles in cellular metabolism, thereby influencing redox signaling through, for instance, the regulation of ROS production in mitochondrial respiration, as well as NADPH recycling in the PPP.”
InfluentialMdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506 · cited 1×
“Under basal conditions, p53 levels are kept low through the action of mouse double minute 2 homolog (MDM2), an E3 ubiquitin ligase that binds to the N-terminus of p53 and targets it for proteasomal degradation on poly-ubiquitinalytion (14, 19, 60).”
Sies, H., Berndt, C., & Jones, D. P. (2017) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-045037 · Cited by 3,520 · cited 1×
“A definition of what levels of H 2 O 2 can be considered oxidative stress and what redox signaling has been proposed by Sies et al. is required (146).”
Ferroptosis as a p53-mediated activity during tumour suppression
Jiang, L., Kon, N., Li, T., Wang, S.-J., Su, T., Hibshoosh, H., Baer, R., & Gu, W. (2015) · Nature · doi:10.1038/nature14344 · Cited by 3,398 · cited 1×
“Conversely, p53 downregulates SLC7A11, a cystine/glutamate antiporter also known as xCT that also ensures the maintenance of sufficient GSH levels to keep GPX4 active, thereby promoting ferrop-tosis (80).”
FSP1 is a glutathione-independent ferroptosis suppressor
Doll, S., Freitas, F. P., Shah, R., Aldrovandi, M., da Silva, M. C., Ingold, I., Goya Grocin, A., Xavier da Silva, T. N., Panzilius, E., Scheel, C. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1707-0 · Cited by 3,341
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113 · cited 15×
“Several clinical trials using MDM2 antagonists as combination therapy have been performed but none has gained FDA approval for cancer treatment so far (157, 185).”
InfluentialCrystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
Cho, Y., Gorina, S., Jeffrey, P. D., & Pavletich, N. P. (1994) · Science · doi:10.1126/science.8023157 · Cited by 2,551 · cited 1×
“Three of these (Cys176, 238, and 242) coordinate a zinc atom together with His179 and, hence, are important to maintain the p53 structure (34).”
A model for p53-induced apoptosis
Polyak, K., Xia, Y., Zweier, J. L., Kinzler, K. W., & Vogelstein, B. (1997) · Nature · doi:10.1038/38525 · Cited by 2,500
Mammalian thioredoxin is a direct inhibitor of apoptosis signal‐regulating kinase (ASK) 1
Saitoh, M., Nishitoh, H., Fujii, M., Takeda, K., Tobiume, K., Sawada, Y., Kawabata, M., Miyazono, K., & Ichijo, H. (1998) · The EMBO Journal · doi:10.1093/emboj/17.9.2596 · Cited by 2,377
DNA damage-induced phosphorylation of p53 alleviates inhibition by MDM2
Shieh, S.-Y., Ikeda, M., Taya, Y., & Prives, C. (1997) · Cell · doi:10.1016/s0092-8674(00)80416-x · Cited by 2,100 · cited 15×
“Several clinical trials using MDM2 antagonists as combination therapy have been performed but none has gained FDA approval for cancer treatment so far (157, 185).”
InfluentialTIGAR, a p53-Inducible Regulator of Glycolysis and Apoptosis
Bensaad, K., Tsuruta, A., Selak, M. A., Vidal, M. N. C., Nakano, K., Bartrons, R., Gottlieb, E., & Vousden, K. H. (2006) · Cell · doi:10.1016/j.cell.2006.05.036 · Cited by 2,019 · cited 1×
“In addition, p53-induced TP53-induced glycolysis and apoptosis regulator (TIGAR) inhibits the activity of phospho-fructokinase 1 (PFK1), the enzyme that catalyzes the rate-limiting step in glycolysis and thereby shuttles glucose into the PPP (11, 12).”
Definition of a consensus binding site for p53
El-Deiry, W. S., Kern, S. E., Pietenpol, J. A., Kinzler, K. W., & Vogelstein, B. (1992) · Nature Genetics · doi:10.1038/ng0492-45 · Cited by 1,985 · cited 1×
“Generally, the RE is composed of two copies of the palindromic consensus sequence PuPuPuC(A/T)(A/ T)GPyPyPy, separated by 0–13 bp (46). p53 transcriptionally regulates a large amount of target genes that are implicated in various biological processes that contribute to its function as a tumor…”
Transcriptional control of human p53-regulated genes
Riley, T., Sontag, E., Chen, P., & Levine, A. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2395 · Cited by 1,921 · cited 1×
“…T)GPyPyPy, separated by 0–13 bp (46). p53 transcriptionally regulates a large amount of target genes that are implicated in various biological processes that contribute to its function as a tumor suppressor, including DNA damage repair, cell cycle arrest, senescence, and apoptosis (131).”
p53 Regulates Mitochondrial Respiration
Matoba, S., Kang, J.-G., Patino, W. D., Wragg, A., Boehm, M., Gavrilova, O., Hurley, P. J., Bunz, F., & Hwang, P. M. (2006) · Science · doi:10.1126/science.1126863 · Cited by 1,650 · cited 1×
“…health and promotes OXPHOS through the transcription of cytochrome c oxidase subunit 1 ( COX1 ) (119), synthesis of cytochrome c oxidase 2 ( SCO2 ) (106), and induction of AIF, a mitochondrial protein that facilitates the proper assembly and function of respiratory complex I (149, 160) but that…”
Petitjean, A., Mathe, E., Kato, S., Ishioka, C., Tavtigian, S. V., Hainaut, P., & Olivier, M. (2007) · Human Mutation · doi:10.1002/humu.20495 · Cited by 1,598 · cited 1×
“Approximately 95% of the mutations that hamper p53 function found in cancer are located in the core DBD (55), 75% of which are missense mutations that result in loss of p53 wild-type function (125).”
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308 · cited 1×
“In addition to loss of tumor suppressive function, so called p53 gain-of-function variants are found in cancer, which confer the protein with oncogenic features that contribute to enhanced proliferation or that promote metastasis (98, 120).”
Post-translational modification of p53 in tumorigenesis
Bode, A. M., & Dong, Z. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1455 · Cited by 1,270
DNA damage activates p53 through a phosphorylation–acetylation cascade
Sakaguchi, K., Herrera, J. E., Saito, S., Miki, T., Bustin, M., Vassilev, A., Anderson, C. W., & Appella, E. (1998) · Genes & Development · doi:10.1101/gad.12.18.2831 · Cited by 1,204 · cited 1×
“Besides serine phosphorylation as a means to facilitate p53 activation on DNA damage, lysine acetylation also positively regulates p53 activation by de-stabilizing the MDM2-p53 interaction and enhancing p53 transcriptional response on DNA damage (76, 134).”
Census and evaluation of p53 target genes
Fischer, M. (2017) · Oncogene · doi:10.1038/onc.2016.502 · Cited by 971
Vousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959 · cited 1×
“Contrary to its role as a tumor suppressor, it has been suggested that in some cases the role of p53 in metabolism actually may support cancer cells to adapt to the harsh environments, thereby supporting tumor growth [reviewed in Vousden and Ryan (169)].”
The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity
Xie, Y., Zhu, S., Song, X., Sun, X., Fan, Y., Liu, J., Zhong, M., Yuan, H., Zhang, L., Billiar, T. R., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.07.055 · Cited by 952
Targeting mutant p53 for efficient cancer therapy
Bykov, V. J. N., Eriksson, S. E., Bianchi, J., & Wiman, K. G. (2018) · Nature Reviews Cancer · doi:10.1038/nrc.2017.109 · Cited by 889 · cited 3×
“Color images are available online. effects of several of these compounds turned out to derive from elevated ROS levels (9, 24, 184).”
Awakening guardian angels: drugging the p53 pathway
Brown, C. J., Lain, S., Verma, C. S., Fersht, A. R., & Lane, D. P. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2763 · Cited by 881 · cited 2×
“When cells encounter stress, p53 undergoes PTMs on certain residues, for example, phosphorylation on S15, 20, and 37 after DNA damage, that interrupt the interaction with MDM2, thereby facilitating p53 stabilization (143, 187).”
Glutaminase 2, a novel p53 target gene regulating energy metabolism and antioxidant function
Hu, W., Zhang, C., Wu, R., Sun, Y., Levine, A., & Feng, Z. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1001006107 · Cited by 862
Sherr, C. J., & Weber, J. D. (2000) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)00038-6 · Cited by 654
Peroxiredoxin functions as a peroxidase and a regulator and sensor of local peroxides
Rhee, S. G., Woo, H. A., Kil, I. S., & Bae, S. H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.r111.283432 · Cited by 603 · cited 1×
“3B), where it transfers the oxidation to client proteins (41, 130, 148, 150, 151, 166).”
Inactivation of the p53 pathway in retinoblastoma
Laurie, N. A., Donovan, S. L., Shih, C.-S., Zhang, J., Mills, N., Fuller, C., Teunisse, A., Lam, S., Ramos, Y., Mohan, A., et al. (2006) · Nature · doi:10.1038/nature05194 · Cited by 595
MDM2–HDAC1-mediated deacetylation of p53 is required for its degradation
Ito, A., Kawaguchi, Y., Lai, C., Kovacs, J. J., Higashimoto, Y., Appella, E., & Yao, T. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf616 · Cited by 570 · cited 1×
“(75, 76).”
Rhee, S. G., & Woo, H. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3393 · Cited by 463
Tumour-associated mutant p53 drives the Warburg effect
Zhang, C., Liu, J., Liang, Y., Wu, R., Zhao, Y., Hong, X., Lin, M., Yu, H., Liu, L., Levine, A. J., et al. (2013) · Nature Communications · doi:10.1038/ncomms3935 · Cited by 434 · cited 1×
“…and, in line with this, loss of p53 leads to a more glycolytic phenotype in cancer cells, which may underlie the so-called ‘‘Warburg effect’’ (164). p53 lowers glycolysis through transcriptional downregulation of glucose transporters (GLUT1 and GLUT4) and thus inhibits glucose uptake (186).”
Structural Basis of DNA Recognition by p53 Tetramers
Kitayner, M., Rozenberg, H., Kessler, N., Rabinovich, D., Shaulov, L., Haran, T. E., & Shakked, Z. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.05.015 · Cited by 408
p53 modifications: exquisite decorations of the powerful guardian
Liu, Y., Tavana, O., & Gu, W. (2019) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjz060 · Cited by 392
Chang, T.-S., Jeong, W., Woo, H. A., Lee, S. M., Park, S., & Rhee, S. G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409482200 · Cited by 388 · cited 1×
“Sulfinic acid can be reduced by sul-firedoxin1 (SRX1) (13, 28) at the expense of ATP, whereas sulfonic acid can no longer be reduced in vivo .”
The pathological response to DNA damage does not contribute to p53-mediated tumour suppression
Christophorou, M. A., Ringshausen, I., Finch, A. J., Swigart, L. B., & Evan, G. I. (2006) · Nature · doi:10.1038/nature05077 · Cited by 382
A p53 Amino-Terminal Nuclear Export Signal Inhibited by DNA Damage-Induced Phosphorylation
Zhang, Y., & Xiong, Y. (2001) · Science · doi:10.1126/science.1058637 · Cited by 378 · cited 2×
“When cells encounter stress, p53 undergoes PTMs on certain residues, for example, phosphorylation on S15, 20, and 37 after DNA damage, that interrupt the interaction with MDM2, thereby facilitating p53 stabilization (143, 187).”
The superoxide‐producing NAD(P)H oxidase Nox4 in the nucleus of human vascular endothelial cells
Kuroda, J., Nakagawa, K., Yamasaki, T., Nakamura, K., Takeya, R., Kuribayashi, F., Imajoh‐Ohmi, S., Igarashi, K., Shibata, Y., Sueishi, K., et al. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00907.x · Cited by 275 · cited 1×
“Oxidative DNA damage may also derive from ROS-producing enzymes that reside within the nucleus, such as NADPH oxidase 4 (NOX4) (91) and the chromatin remodeler lysine-specific histone demethylase 1A (LSD1) (124).”
Redox-sensitive cysteines bridge p300/CBP-mediated acetylation and FoxO4 activity
Dansen, T. B., Smits, L. M. M., van Triest, M. H., de Keizer, P. L. J., van Leenen, D., Koerkamp, M. G., Szypowska, A., Meppelink, A., Brenkman, A. B., Yodoi, J., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.194 · Cited by 201 · cited 1×
“Another way in which redox signaling could influence the choice of transcriptional targets of p53 can be through redox-dependent interactions with, for instance, transcriptional co-activators or chromatin remodelers, as has been shown for forkhead box O (FOXO) transcription factors (40).”
Self-citationRegulation of AIF expression by p53
Stambolsky, P., Weisz, L., Shats, I., Klein, Y., Goldfinger, N., Oren, M., & Rotter, V (2006) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401965 · Cited by 194
Brooks, C. L., & Gu, W. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.022 · Cited by 186 · cited 1×
“Under basal conditions, p53 levels are kept low through the action of mouse double minute 2 homolog (MDM2), an E3 ubiquitin ligase that binds to the N-terminus of p53 and targets it for proteasomal degradation on poly-ubiquitinalytion (14, 19, 60).”
Stress-mediated nuclear stabilization of p53 is regulated by ubiquitination and importin-α3 binding
Marchenko, N. D., Hanel, W., Li, D., Becker, K., Reich, N., & Moll, U. M. (2010) · Cell Death & Differentiation · doi:10.1038/cdd.2009.173 · Cited by 123 · cited 1×
“Generally, DNA damage-activated p53 accumulates in the nucleus (104, 187) and induces the transcription of many target genes involved in the DDR ( e.g. , growth arrest and DNA damage-inducible protein 45 alpha [GADD45a]), cell cycle arrest or senescence ( e.g. , p21), and apoptosis ( e.g. , Bax,…”
Chen, K., Albano, A., Ho, A., & Keaney, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304423200 · Cited by 95 · cited 1×
“…with a minimum of collateral DNA damage and toxicity. p53 has long been known to be activated in response to elevated reactive oxygen species (ROS) (56, 101, 111), and oxidative post-translational modification (PTM) of its cysteines was suggested to be implicated from early on (27, 29, 56, 71, 128).”
Pharmacological reactivation of p53 as a strategy to treat cancer
Zawacka‐Pankau, J., & Selivanova, G. (2015) · Journal of Internal Medicine · doi:10.1111/joim.12336 · Cited by 82
Cleaver, J. E., Brennan-Minnella, A. M., Swanson, R. A., Fong, K.-W., Chen, J., Chou, K.-M., Chen, Y.-W., Revet, I., & Bezrookove, V. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1414135111 · Cited by 65
Wang, S.-J., Yu, G., Jiang, L., Li, T., Lin, Q., Tang, Y., & Gu, W. (2013) · Cell Cycle · doi:10.4161/cc.23597 · Cited by 54 · cited 1×
“…for the electron transport chain-and OXPHOS-dependent ATP production and thus supporting cell survival, for instance, under metabolic stress (172). p53 facilitates the transport of fatty acid to mitochondria through the induction of carnitine O-octanoyltransferase expression (84), and it…”
Cited by
Defining roles of specific reactive oxygen species (ROS) in cell biology and physiology
Sies, H., Belousov, V. V., Chandel, N. S., Davies, M. J., Jones, D. P., Mann, G. E., Murphy, M. P., Yamamoto, M., & Winterbourn, C. (2022) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-022-00456-z · Cited by 1,735
Interplay of oxidative stress, cellular communication and signaling pathways in cancer
Iqbal, M. J., Kabeer, A., Abbas, Z., Siddiqui, H. A., Calina, D., Sharifi-Rad, J., & Cho, W. C. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01398-5 · Cited by 418
Metadata
- Authors
- Shi, T., & Dansen, T. B.
- Venue
- Antioxidants & Redox Signaling
- Publisher
- SAGE Publications
- Published
- 2020-10-20
- Volume
- 33
- Issue
- 12
- Pages
- 839-859
- ISSN
- 1523-0864 (ISSN-L)
- 1557-7716
- OpenAlex
- W3012227346
- Cited by
- 160
- References
- 47
- FWCI
- 5.12
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.